BioPorto A/S
BIOPOR
Rank in Stocks
#22665
BioPorto A/S is a Danish in-vitro diagnostics specialist, supplying biomarker... BioPorto A/S is a Danish in-vitro diagnostics specialist, supplying biomarker tests, research tools, and antibodies to medical professionals and scientists worldwide, with operations across Europe, North America, and Asia. Among its offerings is the neutrophil gelatinase-associated lipocalin (NGAL) test, a precise quantitative particle-enhanced turbidimetric immunoassay designed for use on automated chemistry analyzers. The company further provides monoclonal antibodies essential for scientific, pharmaceutical, and clinical investigations. Additionally, BioPorto produces enzyme-linked immunosorbent assay (ELISA) kits and a versatile rapid assay device tailored for custom lateral flow assay development. Established in 1917, the company is headquartered in Hellerup, Denmark.
Share Price
$0.16432993
Last synced: 2026-10-19
Market Cap
$81.36M
Change (1 day)
-0.48%
Change (1 year)
-42.94%
Country
DK
Trade BioPorto A/S (BIOPOR)
Category
Healthcare
Stock split history for BioPorto A/S (BIOPOR)
BioPorto A/S stock (symbol: BIOPOR) underwent a total of 0 stock splits.
The most recent stock split occurred on Oct 20, 2026.
One BIOPOR share bought prior to Oct 20, 2026 would equal to 0 BIOPOR shares today.
The most recent stock split occurred on Oct 20, 2026.
One BIOPOR share bought prior to Oct 20, 2026 would equal to 0 BIOPOR shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| Not enough data for the provided dates. | |||
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 8 | x34 |
US
|
|
| 7 | x47 |
US
|
|
| 0 | - |
US
|
|
| 0 | - |
CN
|
|
| 1 | x1 |
US
|
